<DOC>
	<DOCNO>NCT01878695</DOCNO>
	<brief_summary>NAC N-acetyl derivative naturally occur amino acid , L-cysteine . It common over-the-counter supplement also available injectable pharmaceutical protects liver case acetaminophen overdose . In exercise physiology literature , oral injectable NAC show reduce fatigue improve recovery exertion interesting implication explore cancer-related fatigue . In term cancer cell biology , reactive oxygen specie ( ROS ) may play important role development progression breast cancer</brief_summary>
	<brief_title>Pilot Study Anti-oxidant Supplementation With N-Acetyl Cysteine Stage 0/I Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Demographic • Females ≥18 year age Disease relate Stage 0/I breast cancer biopsy ( patient may consent screen suspected breast cancer , treatment occur cancer confirm biopsy ) . Awaiting surgery consist either lumpectomy mastectomy . ECOG performance status 01 Laboratory Laboratory value would prevent patient receive treatment determine PI study oncologist Serum creatinine ≤2.0 mg/dL Serum bilirubin ≤2.0 X ULN Serum HgB ≥8.0 mg/dL General Competent comprehend , sign , date IRBapproved inform consent form Female subject childbearing potential negative pregnancy test Disease Related History know presence metastasis History another primary cancer , except : Curatively treat cervical carcinoma situ , Curatively resect nonmelanomatous skin cancer , Other primary solid tumor curatively treat know active disease present treatment administer ≤ 3 year prior enrollment Other concurrent anticancer chemotherapy within 4 week determine PI Any comorbid disease would increase risk toxicity determine PI Medications/Treatments Subjects require chronic use immunosuppressive agent ( eg , methotrexate , cyclosporine , corticosteroid ) Recent infection require course systemic antiinfectives complete ≤ 14 day prior enrollment ( exception make judgment PI oral treatment uncomplicated urinary tract infection ( [ UTI ] ) General History medical psychiatric condition addictive disorder , laboratory abnormality , opinion PI , may increase risk associate study participation study drug administration may interfere conduct study interpretation study requirement History bronchospasm severe asthma determine PI Subject unwilling unable comply study requirement Known positive test ( ) human immunodeficiency virus infection , hepatitis C virus , chronic active hepatitis B infection Documented history alcohol , cocaine intravenous drug abuse ≤ 6 month enrollment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Integrative Medicine</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Stage 0</keyword>
	<keyword>Stage 1</keyword>
</DOC>